DIANA HAMPTON, M.D.
Ophthalmology Physician in OKLAHOMA CITY, Oklahoma. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DIANA HAMPTON, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 1,264 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 1K
- Part D claims, 2023
- 55%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DIANA HAMPTON, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
DIANA HAMPTON, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about DIANA HAMPTON, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Oklahoma
How Ophthalmology Physician compares to other specialties among Oklahoma providers
Ophthalmology Physician share within Oklahoma
Ophthalmology Physician is one of the more visible NUCC categories in Oklahoma
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DIANA HAMPTON, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DIANA HAMPTON, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 13401 N WESTERN AVE, OKLAHOMA CITY, OK, 73114, with a listed phone of (405) 608-8820. NPI 1669449013 was issued on 03/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAMPTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,264 prescription claims written by this provider, covering 291 Medicare beneficiaries and totaling roughly $161K in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1669449013 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 03/03/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DIANA HAMPTON, M.D.'s current license status, disciplinary history, and board certifications with the Oklahoma State Board of Medical Licensure in Oklahoma before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DIANA HAMPTON, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$206
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
45% brand-name claims vs 55% generic, on 1,264 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,027
- Total Day Supply
- 55,662
- Brand vs Generic
- 45% brand / 55% generic
- Brand Drug Cost
- $121K
- Generic Drug Cost
- $40K
- Antibiotic Claims
- 34
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 1.24
- Gender Split
- 61% female / 39% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DIANA HAMPTON, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
513 claims
- Timolol Maleate
Timolol Maleate
255 claims
- Lumigan 69
Lumigan
69 claims
- Neomycin-Polymyxin… 69
Neomycin-Polymyxin-Dexameth
69 claims
- Travoprost 56
Travoprost
56 claims
- Brimonidine Tartrate 36
Brimonidine Tartrate
36 claims
- Brimonidine Tartra… 32
Brimonidine Tartrate-Timolol
32 claims
- Combigan 25
Combigan
25 claims
| Drug | Claims |
|---|---|
| Latanoprost | 513 |
| Timolol Maleate | 255 |
| Lumigan Bimatoprost | 69 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 69 |
| Travoprost | 56 |
| Brimonidine Tartrate | 36 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 32 |
| Combigan Brimonidine Tartrate/Timolol | 25 |
| Prednisolone Acetate | 24 |
| Cephalexin | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How DIANA HAMPTON, M.D. fits within the Ophthalmology Physician landscape nationally.
DIANA HAMPTON, M.D.'s 1,264 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as HAMPTON.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Oklahoma
Frequently Asked Questions
What is DIANA HAMPTON, M.D.'s specialty? ▼
How much does DIANA HAMPTON, M.D. prescribe under Medicare Part D? ▼
What is DIANA HAMPTON, M.D.'s Medicare quality score? ▼
Where is DIANA HAMPTON, M.D. located? ▼
What is DIANA HAMPTON, M.D.'s NPI number? ▼
Does DIANA HAMPTON, M.D. prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does DIANA HAMPTON, M.D. prescribe most often? ▼
Does DIANA HAMPTON, M.D. accept Medicare? ▼
How can I verify DIANA HAMPTON, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology